The partnership between francophone countries1 and the Global Fund in the fight against HIV, tuberculosis (TB) and malaria has achieved tremendous impact over the last two decades. Since its inception, the Global Fund has invested US$14.6 billion in the fight against the three diseases in francophone countries:
US$6.6 billion for HIV and AIDS, US$6.4 billion for malaria and US$1.1 billion for TB. These investments – which make up 24% of the overall Global Fund portfolio – coupled with domestic finances from countries where the Global Fund invests have achieved great results.
As of 2022, health programs supported by the Global Fund partnership have helped to save 7.1 million lives in these countries.
The Global Fund’s Strategy, “Fighting Pandemics and Building a Healthier and More Equitable World” (2023-2028) puts greater emphasis on equity, sustainability, program quality and innovation. The Strategy takes determined action to tackle human rights and gender-related barriers and leverage the fight against HIV, TB and malaria to build more inclusive, resilient and sustainable systems for health, which are better able to deliver health and well-being and to prevent, identify and respond to pandemics.